1) liver microsomes incubation
肝微粒体孵育
1.
CYP3A5 protein quantity was determined by western-blot;After liver microsomes incubation with CsA and ketoconazole,the AM9 and CsA concentration was detected by LC/.
采用AM9/CsA来评估CYP3A5活性,人肝微粒体孵育环孢素,CYP3A5*1/*1的活性明显强于CYP3A5*3/*3;量化校正CYP3A5后,此活性不存在性别差异。
2) liver microsome incubation
肝微粒体体外温孵
3) The measure which is co-incubated with rat hepatic mircrosome
肝微粒体体外温孵法
4) liver microsomes
肝微粒体
1.
CYP3A1/2 and 2C9/10 in rat liver microsomes mediate 22α-and 24-hydroxylation of 18α-glycyrrhetic acid;
大鼠肝微粒体CYP3A1/2和CYP2C9/10参与甘草次酸羟化代谢
2.
Determination of puerarin in rat liver microsomes by LC-MS and its pharmacokinetics;
大鼠肝微粒体中葛根素的液相色谱-质谱测定法及药物代谢动力学
3.
Gender difference in ranolazine metabolism in rat liver microsomes;
盐酸雷诺嗪在大鼠肝微粒体内代谢的性别差异
5) hepatic microsome
肝微粒体
1.
Effect of influence on levels of LPO and SOD of hepatic microsome in mice of Yuzhiling;
预知灵对小白鼠肝微粒体LPO及SOD活性的影响
2.
Cytochrome P450 contents and activity in hepatic microsome of grass carp(Ctenopharyngodon idellus);
草鱼肝微粒体的提取及CYP酶活性的测定
6) microsomes
肝微粒体
1.
Methods Liver microsomes were preparated from normal human liver, which was subjucted to be treated with a series of concentrations of CsA or coadministration with MP.
方法在人肝微粒体中单独使用CsA和联用甲基强的松龙,以红霉素为底物,经过NADPH系统孵育后,分别测定肝微粒体的红霉素N-脱甲基酶(ERD)活性。
2.
The activities oi CYP3A in the microsomes were detected by using erythromycin as substrate.
方法:制备大鼠和人肝微粒体,用不同浓度的CsA作用、加或不加MP、Flu,以红霉素为底物,经过NADPH系统孵育后,利用分光光度法测定人和大鼠肝微粒体的红霉素N-脱甲基酶(ERD)活性。
3.
The activities of CYP3A in the microsomes were detected by using erythromycin as substrate.
方法：(1)分别制备大鼠和人肝微粒体，加入不同浓度的CsA0μmol／l、10μmol／l、20μmol／l、40μmol／l作用，以红霉素为底物，经过NADPH系统孵育后，利用分光光度法测定人和大鼠肝微粒体的红霉素N-脱甲基酶(ERD)活性。
补充资料：孵育箱
分子式：
CAS号：
性质：见培养箱
CAS号：
性质：见培养箱
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条